Therapies for Children With Autism Spectrum Disorders

Evidence Table. Therapies for children with ASD (continued)
Study
Inclusion/ Exclusion Baseline
Description Intervention
Criteria/ Population Measures Outcomes
not clear
Caucasian: 4 (36)
G2: 29.4 ± 22.65
Groups:
Caucasian/Hispanic: 2(18)
Post-treatment:
G1: treatment/placebo Hispanic: 2(18)
G1: 21.5 ± 23.3
G2: placebo/treatment Caucasian/Native
G2: 34.4 ± 25
Provider:
American: 1 (9)
ANOVA: group
Two trained assistants Caucasian/Native
(P = NS), time
Measure of treatment American/Hispanic: 1 (9)
(P = 0.04), time Х
fidelity reported: Pacific Islander: 1 (9)
group (P = 0.63)
No
SES:
Harms:
Co-interventions held Maternal education: NR
NR
stable during treatment: Household income: NR
Modifiers:
NR
Diagnostic approach:
NR
Concomitant therapies : In study
NR
Diagnostic tool/method:
N at enrollment: DSM-IV criteria confirmed
G1: 6
by ADOS and clinical
G2: 5
judgment
N at follow-up:
Diagnostic category, n
G1: 6
(%):
G2: 5
Autism: 11 (100)
Other characteristics:
NR
Author:
Intervention:
Inclusion criteria: Sensory:
Sensory:
Fazlioglu et al., Sensory integration • Low functioning children Sensory Evaluation Sensory
2008
program based on “The with autism
for Children with Evaluation for
Country: Sensory Diet”, admini- • Attended the Trakya Autism score, mean Children with
Turkey
Practice
setting:
Academic
Intervention
setting:
Clinic
Enrollment
period:
NR
Funding:
NR
Author industry
relationship
disclosures:
NR
Design:
RCT
stered in a specially University Training and
arranged room at the Research Center for
center, 45 minutes per Mentally and Physically
session, 2 sessions per Handicapped Children
week for 24 sessions total • Ages 7-11 years
Control group, matched Exclusion criteria:
for age, gender, and level • Previous participation in
of function, attended a sensory integration
regularly scheduled program
special education • History of epileptic
classrooms at the center, seizures
no sensory integration Age, years (range):
program
NR (7-11)
Assessments:
Mental age:
observations (admini- NR
strator NR)
Gender, n (%):
Groups:
Male:
G1: experimental G1: 12 (80)
G2: control group G2: 12 (80)
Provider:
Female:
Special educator G1: 3 (20)
Measure of treatment G2: 3 (20)
fidelity reported: Race/ethnicity:
No
NR
Co-interventions held SES:
stable during treatment: Maternal education: NR
NR
Household income: NR
Concomitant therapies: Diagnostic approach:
NR
NR
N at enrollment: Diagnostic tool/method:
G1: 15
DSM-IV
± SD:
G1: 98.2 ± 19.3
G2: 95.8 ± 17.0
Autism score,
mean ± SD:
G1: 66.5 ± 11.4
G2: 97.3 ± 17.8
G1/G2: P < 0.01
Harms:
NR
Modifiers:
NR
C-142